导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -11.05% | 3836/4773 |
| 近一周 | -1.51% | 489/5462 |
| 近一月 | -7.67% | 3921/5421 |
| 近一季 | -15.54% | 4304/5209 |
| 近半年 | -20.46% | 4397/4920 |
| 近一年 | -5.57% | 3151/4366 |
| 近两年 | 35.89% | 2056/2954 |
| 近三年 | 5.71% | 1823/2253 |
| 成立以来 | 40.34% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.22% 560/4961 |
1.45% 3022/5312 |
- - |
- - |
| 2025 | 27.89% 1527/4813 |
-3.99% 3117/3635 |
0.20% 2739/4076 |
34.99% 1007/4524 |
-1.51% 2957/4813 |
| 2024 | 2.20% 1982/3463 |
-2.28% 1344/2808 |
-7.60% 2103/3014 |
17.96% 1088/3129 |
-4.05% 2424/3463 |
| 2023 | -28.69% 2043/2656 |
-2.74% 2047/2280 |
-5.51% 1478/2385 |
-14.63% 2190/2515 |
-9.11% 2324/2655 |
| 2022 | -23.24% 1120/2207 |
-14.79% 1000/1919 |
13.86% 215/2016 |
-15.62% 1322/2113 |
-6.25% 1985/2208 |
| 2021 | 50.46% 2/1822 |
-3.33% 801/1255 |
29.94% 44/1330 |
18.65% 61/1466 |
0.94% 1037/1822 |
| 2020 | - - |
- - |
- - |
- - |
- - |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 申万菱信中证环保产业指数(LOF)C VS. 长安沪深300非周期A(740101) |